ARTICLE;
CONTROLLED STUDY;
DOSAGE SCHEDULE COMPARISON;
DRUG ABSORPTION;
DRUG BLOOD LEVEL;
DRUG DOSAGE FORM COMPARISON;
DRUG FORMULATION;
DRUG RELEASE;
DRUG SOLUBILITY;
DRUG STRUCTURE;
FUSED SOLID DISPERSION;
HUMAN;
HUMAN EXPERIMENT;
NORMAL HUMAN;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
AREA UNDER CURVE;
CHEMISTRY, PHARMACEUTICAL;
CROSS-OVER STUDIES;
DELAYED-ACTION PREPARATIONS;
HUMANS;
IBUPROFEN;
SOLUBILITY;
STEREOISOMERISM;
TABLETS;
X-RAY DIFFRACTION;
Pharmacological differences between the optical isomers of ibuprofen evidence for metabolic inversion of the (-) isomer
S. S. Adams P. Bresloff C. G. Mason 1976 Pharmacological differences between the optical isomers of ibuprofen evidence for metabolic inversion of the (-) isomer J. Pharm. Pharmacol. 28 256 257
(S)-(+)-ibuprofenbased hydrogelators: An approach toward anti-inframmatory drug delivery
S. Bhuniya Y. J. Seo B. H. Kim 2006 (S)-(+)-ibuprofenbased hydrogelators: an approach toward anti-inframmatory drug delivery Tetrahederon Letters 47 7153 7156
The metabolic chiral inversion and disposition enantioselectivity of the 2-arylpropionic acids and their biological consequences
J. Cardwell A. J. Hutt S. Fournel-Gigleux 1988 The metabolic chiral inversion and disposition enantioselectivity of the 2-arylpropionic acids and their biological consequences Biochem. Pharmacol. 37 105 114
Efficacy and safety of ibuprofen arginine in the treatment of primary dysmenorrhoea
7
C. Castelo-Branco G. Casals J. Haya M. Cancelo J. Manasanch 2004 Efficacy and safety of ibuprofen arginine in the treatment of primary dysmenorrhoea Clinical Drug Investigation 24 7 385 393
Development and evaluation of a multiple-unit oral sustained release dosage form for S(+)-ibuprofen: Preparation and release kinetics
P. J. Cox K. A. Khan D. L. Munday 1999 Development and evaluation of a multiple-unit oral sustained release dosage form for S(+)-ibuprofen: preparation and release kinetics Int. J. of Pharm. 193 73 84
Pharmacokinetics of dexibuprofen administered as 200 mg and 400 mg film-coated tablets in healthy volunteers
8
N. Eller C. J. Kollenz 1998 Pharmacokinetics of dexibuprofen administered as 200 mg and 400 mg film-coated tablets in healthy volunteers Int. J. Clin. Pharmacol. Ther. 36 8 414 417
Pharmacokinetics of S(+)- and R(-)-ibuprofen in volunteers and first clinical experience of S(+)-ibuprofen in rheumatoid arthritis
G. Geisslinger O. Schuster K. P. Stock G. L. Bach D. Loew K. Brune 1990 Pharmacokinetics of S(+)- and R(-)-ibuprofen in volunteers and first clinical experience of S(+)-ibuprofen in rheumatoid arthritis Eur. J. Clin. Pharmacol. 38 493 497
Stereospecific formulation and characterization of sustained release ibuprofen microsphere
4
R. K. Janjikhel C. M. Adeyeye 1997 Stereospecific formulation and characterization of sustained release ibuprofen microsphere J. Microencapsulation 14 4 409 426
Stereoselective disposition of ibuprofen enantiomers in man
E. J. D. Lee K. Williams R. Day G. Graham D. Champion 1985 Stereoselective disposition of ibuprofen enantiomers in man Br. J. Clin Pharmacol. 19 669 674
